Anavex Life Sciences Corp (AVXL)
3.775
+0.10
(+2.58%)
USD |
NASDAQ |
Apr 23, 13:16
Anavex Life Sciences Market Cap: 309.97M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 302.17M |
| April 19, 2024 | 310.39M |
| April 18, 2024 | 312.03M |
| April 17, 2024 | 334.20M |
| April 16, 2024 | 338.30M |
| April 15, 2024 | 347.34M |
| April 12, 2024 | 352.67M |
| April 11, 2024 | 365.40M |
| April 10, 2024 | 352.26M |
| April 09, 2024 | 360.47M |
| April 08, 2024 | 360.47M |
| April 05, 2024 | 362.94M |
| April 04, 2024 | 367.86M |
| April 03, 2024 | 379.36M |
| April 02, 2024 | 372.79M |
| April 01, 2024 | 412.20M |
| March 28, 2024 | 417.95M |
| March 27, 2024 | 415.49M |
| March 26, 2024 | 397.42M |
| March 25, 2024 | 373.61M |
| March 22, 2024 | 382.64M |
| March 21, 2024 | 419.59M |
| March 20, 2024 | 420.42M |
| March 19, 2024 | 397.42M |
| March 18, 2024 | 395.78M |
| Date | Value |
|---|---|
| March 15, 2024 | 419.59M |
| March 14, 2024 | 422.06M |
| March 13, 2024 | 441.77M |
| March 12, 2024 | 426.98M |
| March 11, 2024 | 426.16M |
| March 08, 2024 | 447.51M |
| March 07, 2024 | 426.16M |
| March 06, 2024 | 412.20M |
| March 05, 2024 | 408.92M |
| March 04, 2024 | 419.59M |
| March 01, 2024 | 433.55M |
| February 29, 2024 | 422.06M |
| February 28, 2024 | 435.20M |
| February 27, 2024 | 437.66M |
| February 26, 2024 | 408.92M |
| February 23, 2024 | 403.99M |
| February 22, 2024 | 411.38M |
| February 21, 2024 | 417.13M |
| February 20, 2024 | 440.12M |
| February 16, 2024 | 465.58M |
| February 15, 2024 | 478.72M |
| February 14, 2024 | 479.54M |
| February 13, 2024 | 457.78M |
| February 12, 2024 | 504.17M |
| February 09, 2024 | 474.61M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
114.69M
Minimum
Aug 05 2019
2.090B
Maximum
Jun 28 2021
635.79M
Average
648.48M
Median
Market Cap Benchmarks
| Ventyx Biosciences Inc | 258.28M |
| Checkpoint Therapeutics Inc | 53.17M |
| Vertex Pharmaceuticals Inc | 104.42B |
| Sarepta Therapeutics Inc | 11.09B |
| NovaBay Pharmaceuticals Inc | 2.260M |
Market Cap Related Metrics
| Price to Book Value | 2.286 |
| Price | 3.775 |
| Earnings Yield | -14.57% |